Compugen Ltd (CGEN): Compugen to Present at Upcoming Antibody...

Next 10 Prev Next

Send PM Follow Ignore

Followers	144
Posts	28021
Boards Moderated	4
Alias Born	02/07/2004

midastouch017

Re: None

Monday, 06/17/2024 7:49:41 AM

Monday, June 17, 2024 7:49:41 AM

Compugen to Present at Upcoming Antibody Industrial Symposium

https://finance.yahoo.com/news/compugen-present-upcoming-antibody-industrial-110000879.html

HOLON, Israel, June 17, 2024 /PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today announced that Pierre Ferré, Ph.D, SVP, Preclinical Development and Corporate Operations, Compugen will present a case study on clinical dose selection for TIGIT monospecific and bispecific antibodies at the Antibody Industrial Symposium taking place June 20-21, 2024, Montpellier, France.

Event: 12th Antibody Industrial Symposium, Montpellier, France
Date: Friday, June 21, 2024
Presenter: Pierre Ferré, Ph.D., SVP, Preclinical Development and Corporate Operations, Compugen
Presentation title: Case study on clinical dose selection for TIGIT monospecific and bispecific antibodies

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent CGEN News

Form F-3 - Registration statement by foreign private issuers • Edgar (US Regulatory) • 05/18/2026 08:02:35 PM
Compugen surges after revenue tops forecasts despite quarterly loss miss (CGEN) • IH Market News • 05/18/2026 12:35:18 PM
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/18/2026 11:00:20 AM
Compugen Reports First Quarter 2026 Results • PR Newswire (US) • 05/18/2026 11:00:00 AM
Compugen to Participate in 2026 Stifel Virtual Targeted Oncology Forum • PR Newswire (US) • 05/12/2026 11:00:00 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/27/2026 08:03:18 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/27/2026 08:02:06 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 04/27/2026 10:52:43 AM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 04/27/2026 10:40:55 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/15/2026 08:10:27 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/15/2026 08:07:11 PM
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] • Edgar (US Regulatory) • 04/15/2026 08:03:12 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 04/15/2026 10:38:12 AM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 04/15/2026 10:16:38 AM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 04/13/2026 11:28:42 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/09/2026 08:05:10 PM
Compugen to Participate in 25th Annual Needham Virtual Healthcare Conference • PR Newswire (US) • 04/09/2026 11:00:00 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/03/2026 11:31:38 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/03/2026 11:29:40 AM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 04/02/2026 02:06:23 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/30/2026 10:04:03 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/26/2026 02:42:06 PM

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Detailed Quote

Recent CGEN News

More CGEN News

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Recent CGEN News

Go Ad-Free